Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Cooperberg

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Urology|February 23, 2016
When to Start Prostate Cancer Screening and When to Stop: Insights from GöteborgMatthew Cooperberg
European Urology|November 6, 2020
Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6Andrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
European Urology|July 8, 2020
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking GlassAndrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
European Urology|May 12, 2020
Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial EvidenceAndrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
Biometrics|May 30, 2025
Estimating optimally tailored active surveillance strategy under interval censoringMuxuan Liang, Yingqi Zhao, Daniel W Lin, et al.
JCO Global Oncology|April 26, 2023
Reply to X. Farré et alAndrew Vickers, Alejandro Berlin, Gladell Paner, et al.
JAMA Oncology|May 21, 2026
Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as PrecancerousAndrew J Vickers, Matthew Cooperberg, Christian P Pavlovich, et al.
The Journal of Urology|September 21, 2022
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer TreatmentCraig V Labbate, Laurence Klotz, Monica Morrow, et al.
European Urology Focus|April 28, 2023
Physician Perception of Grade Group 1 Prostate CancerRagheed Saoud, Varat Woranisarakul, Gladell P Paner, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Multicolor fluorescence microscopy for surgical guidance using a chip-scale imager with a low-NA fiber optic plate and a multi-bandpass interference filterMicah Roschelle, Rozhan Rabbani, Efthymios Papageorgiou, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Urology|February 23, 2016
When to Start Prostate Cancer Screening and When to Stop: Insights from GöteborgMatthew Cooperberg
European Urology|November 6, 2020
Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6Andrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
European Urology|July 8, 2020
Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial Evidence. Eur Urol 2020;78:304-6. Prebiopsy MRI: Through the Looking GlassAndrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
European Urology|May 12, 2020
Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified by the Clinical Trial EvidenceAndrew Vickers, Sigrid V Carlsson, Matthew Cooperberg
Biometrics|May 30, 2025
Estimating optimally tailored active surveillance strategy under interval censoringMuxuan Liang, Yingqi Zhao, Daniel W Lin, et al.
JCO Global Oncology|April 26, 2023
Reply to X. Farré et alAndrew Vickers, Alejandro Berlin, Gladell Paner, et al.
JAMA Oncology|May 21, 2026
Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as PrecancerousAndrew J Vickers, Matthew Cooperberg, Christian P Pavlovich, et al.
The Journal of Urology|September 21, 2022
Focal Therapy for Prostate Cancer: Evolutionary Parallels to Breast Cancer TreatmentCraig V Labbate, Laurence Klotz, Monica Morrow, et al.
European Urology Focus|April 28, 2023
Physician Perception of Grade Group 1 Prostate CancerRagheed Saoud, Varat Woranisarakul, Gladell P Paner, et al.
Biorxiv : the Preprint Server for Biology|October 31, 2023
Multicolor fluorescence microscopy for surgical guidance using a chip-scale imager with a low-NA fiber optic plate and a multi-bandpass interference filterMicah Roschelle, Rozhan Rabbani, Efthymios Papageorgiou, et al.
Pageof 5